Inventor
GROOTENHUIS PETER DIEDERIK JAN
US36 patents
⚠️ This page may combine multiple inventors who share the name “GROOTENHUIS PETER DIEDERIK JAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
24 patentsUS9974781B2May 22, 2018
Modulators of ATP-binding cassette transporters
VERTEX PHARMA30 citations98
US9550761B2Jan 24, 2017
Modulators of ATP-binding cassette transporters
VERTEX PHARMA43 citations98
US9782408B2Oct 10, 2017
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA33 citations97
US8952050B2Feb 10, 2015
Modulators of ATP-binding cassette transporters
VERTEX PHARMA62 citations97
US8952049B2Feb 10, 2015
Modulators of ATP-binding cassette transporters
VERTEX PHARMA62 citations97
US8796308B2Aug 5, 2014
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA73 citations97
US8835639B2Sep 16, 2014
Process for making modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA72 citations96
US10987348B2Apr 27, 2021
Modulators of ATP-binding cassette transporters
VERTEX PHARMA13 citations94
US10022352B2Jul 17, 2018
Modulators of ATP-binding cassette transporters
VERTEX PHARMA30 citations94
US10793547B2Oct 6, 2020
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA24 citations93
US10758534B2Sep 1, 2020
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA13 citations93
US10258624B2Apr 16, 2019
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA32 citations93
US9511067B2Dec 6, 2016
Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels
VERTEX PHARMA17 citations92
US7678802B2Mar 16, 2010
Quinazolines useful as modulators of ion channels
VERTEX PHARMA16 citations89
US11426407B2Aug 30, 2022
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA6 citations85
US11453655B2Sep 27, 2022
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA8 citations84
US11414439B2Aug 16, 2022
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA6 citations74
US12168009B2Dec 17, 2024
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA1 citations72
US10738030B2Aug 11, 2020
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA6 citations71
US8343763B2Jan 1, 2013
Heterocyclic derivatives as modulators of ion channels
VERTEX PHARMA2 citations62
US12384762B2Aug 12, 2025
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA0 citations61
US9181273B2Nov 10, 2015
Morpholine-spirocyclic piperidine amides as modulators of ion channels
VERTEX PHARMA0 citations51
US12269831B2Apr 8, 2025
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA0 citations48
US10233191B2Mar 19, 2019
Fused piperidine amides as modulators of ion channels
VERTEX PHARMA0 citations39
HADIDA-RUAH SARA SABINA
5 patentsUS8318733B2Nov 27, 2012
Modulators of ATP-binding cassette transporters
HADIDA-RUAH SARA SABINA93 citations98
US8541453B2Sep 24, 2013
Modulators of ATP-binding cassette transporters
HADIDA-RUAH SARA SABINA74 citations97
US8598164B2Dec 3, 2013
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
HADIDA-RUAH SARA SABINA5 citations71
US8828996B2Sep 9, 2014
Morpholine-spirocyclic piperidine amides as modulators of ion channels
HADIDA-RUAH SARA SABINA0 citations50
US9365588B2Jun 14, 2016
Benzoxazines as modulators of ion channels
HADIDA-RUAH SARA SABINA0 citations38